Arrowsmith Genetics

Arrowsmith Genetics is excited to be in Round 3 of the New Ventures BC competition. Looking forward to meeting our mentors and other NVBC ventures. #NVBC2023 #BCtech #BCentrepreneurs

C’était un avant-midi fascinant avec les présentations de @ArrowsmithGx @NoaTherapeutics Nospharma, SPM Therapeutics, @A4i_me, QurCan Therapeutics, Kanyr Pharma, et Protaxis Therapeutics Inc. Une pause dîner bien appréciée et on enchaîne! #innovation #lifesciences #pharma

We are pleased to chosen as one of the Sweet 16 for Sweet Biopharma Day. Looking forward to talk science and innovation with the 2023 cohort.

The federal government announced today a new UBC-led biomedical innovation hub that will accelerate the development and manufacturing of lifesaving medicines for Canadians. Read more: bit.ly/3mU6dSp #ImmunoengineeringHub #CdnBiomanufacturing #CBRFBRIF

@LumiraVentures @ubcentrepreneur Dr. Peter Stirling of @ArrowsmithGx presented their AGx Mutational Target Mapping (MTM) platform, which optimizes drug targeting strategies, leading to new therapeutic candidates.

We kicked off today’s Invest in BC presented by @LumiraVentures with a great fireside chat with Daniel Hétu of Lumira Ventures. He shared how, despite geopolitical challenges, BC’s life sciences sector is well-positioned. Follow the morning’s presentations in the comments.

Invest in BC presented by @LumiraVentures kicks off on November 2nd! At 12:45 pm PT, the third session will commence, and attendees will hear company pitches from the third group of therapeutics companies. More information and registration: lnkd.in/geQTDp4f

Invest in BC presented by @LumiraVentures is happening on November 2nd and 3rd! Check out the first group of companies that are presenting from the Therapeutics sector. Info and registry: lifesciencesbc.ca/event/invest-i… @ArrowsmithGx @clairvoyantrx @IntegratedNTX @MesintelTX